February Highlights
In early February, the CeMCOR team attended a screening of the PBS Documentary film, ‘The M Factor’, organized by The Pink Zones at the Kitsilano Neighbourhood House in Vancouver. The screening was followed by a panel discussion between Dr. Jerilynn Prior, Dr. Heidi Lescanec, and Dr. Sukpreet Patel, moderated by Dr. Thara Vayali.
From left to right–Dr. Thara Vayali, Dr. Jerilynn Prior, Dr. Heidi Lescanec, and Dr. Sukhpreet Patel
The film highlighted the confusion, lack of information, and challenges many face when navigating the menopause transition. Some experience it as a smooth shift, while for others, it can feel like a storm that requires more support. Events like these bring women+ together to share knowledge, break taboos, change misconceptions, and advocate for better healthcare.
At CeMCOR, we offer multiple tools and resources to help support you through these life phases. We’re grateful to be part of this conversation and look forward to more opportunities to support, educate, and empower!
“Awareness of perimenopausal changes, workplace accommodation, and progesterone therapy, if needed, will allow all midlife women to survive and thrive”
– Dr. Jerilynn Prior
Reference List
1. Prior JC, Cameron A, Fung M, et al. Oral micronized progesterone for perimenopausal night sweats and hot flushes a Phase III Canada-wide randomized placebo-controlled 4 month trial. Sci Rep 2023;13(1):9082. doi: https://www.nature.com/articles/s41598-023-35826-w [published Online First: 20230605]
2. Prior JC. Perimenopause: The complex endocrinology of the menopausal transition. Endocrine Reviews1998;19:397-428.
3. Santoro N, Rosenberg J, Adel T, et al. Characterization of reproductive hormonal dynamics in the perimenopause. Journal of Clinical Endocrinology and Metabolism 1996;81:4:1495-501.
4. Freedman RR. Menopausal hot flashes: mechanisms, endocrinology, treatment. J Steroid BiochemMol Biol2014;142:115-20.
5. Berger C, Langsetmo L, Joseph L, et al. Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents. Can Med Assoc J 2008;178 1660-68.
6. Schmidt PJ, Ben DR, Martinez PE, et al. Effects of Estradiol Withdrawal on Mood in Women With Past Perimenopausal Depression: A Randomized Clinical Trial. JAMA Psychiatry 2015;72(7):714-26.
7. Moen MH, Kahn H, Bjerve KS, et al. Menometrorrhagia in the perimenopause is associated with increased serum estradiol. Maturitas 2004;47(2):151-55.
8. Kaufert PA. Menstruation and menstrual change: women in midlife. Health Care Women Int 1986;7(1-2):63-76.
9. Paramsothy P, Harlow SD, Greendale GA, et al. Bleeding patterns during the menopausal transition in the multi-ethnic Study of Women’s Health Across the Nation (SWAN): a prospective cohort study. BJOG2014;121(12):1564-73. doi: 10.1111/1471-0528.12768 [published Online First: 2014/04/17]
10. Hendrix SL, Cochrane BB, Nygaard IE, et al. Effects of estrogen with and without progestin on urinary incontinence. JAMA 2005;293(8):935-48.
11. Prior JC. Women’s Reproductive System as Balanced Estradiol and Progesterone Actions—a revolutionary, paradigm-shifting concept in women’s health. Drug Discovery Today: Disease Models 2020;32:31-40. doi: https://doi.org/10.1016/j.ddmod.2020.11.005
12. Prior JC. Adaptive, reversible, hypothalamic reproductive suppression: More than functional hypothalamic amenorrhea. Frontiers in Endocrinology 2022;13 doi: 10.3389/fendo.2022.893889